Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0000064978-25-000005
Filing Date
2025-05-14
Accepted
2025-05-14 16:02:08
Documents
2
Period of Report
2025-03-31
Effectiveness Date
2025-05-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2252
2 FORM 13-F HR INFO TABLE (3.31.25) 13fhrinfotable033125.html INFORMATION TABLE  
2 FORM 13-F HR INFO TABLE (3.31.25) 13fhrinfotable033125.xml INFORMATION TABLE 6737
  Complete submission text file 0000064978-25-000005.txt   10550
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 13F-HR | Act: 34 | File No.: 028-25193 | Film No.: 25945150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)